Vitamin D: skeletal and extra skeletal effects; recommendations for good practice;Vitamine D : effet osseux et extra-osseux ; recommandations de bon usage

Presse Medicale

Volumn 38, Issue 1, 2009, Pages 43-54

  Briot, Karine ^a   Audran, Maurice ^b   Cortet, Bernard ^c   Fardellone, Patrice ^d   Marcelli, Christian ^e   Orcel, Philippe ^f   Vellas, Bruno ^g   Thomas, Thierry ^h   Roux, Christian ^a  

^a Institut Cochin   (France)

^b Service de rhumatologie   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d AMIENS UNIVERSITY HOSPITAL   (France)

^e CAEN UNIVERSITY HOSPITAL   (France)

^f HÔPITAL LARIBOISIÈRE   (France)

^g TOULOUSE UNIVERSITY HOSPITAL   (France)

^h UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D; 25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; CARDIOVASCULAR AGENT; DRUG DERIVATIVE; VITAMIN;

BONE METABOLISM; CARDIOVASCULAR DISEASE; DRUG EFFECT; HUMAN; INFECTION RISK; INFLAMMATORY DISEASE; MEDICAL PRACTICE; MORTALITY; NEOPLASM; OSTEOARTHRITIS; PREVALENCE; SHORT SURVEY; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; BLOOD; BONE; FRACTURE; NEUROMUSCULAR SYNAPSE; OSTEOPOROSIS; PHYSIOLOGY; REVIEW; SKELETAL MUSCLE;

ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; BONE AND BONES; CARDIOVASCULAR AGENTS; FRACTURES, BONE; HUMANS; MUSCLE, SKELETAL; NEUROMUSCULAR JUNCTION; OSTEOARTHRITIS; OSTEOPOROSIS; VITAMIN D; VITAMINS;

EID: 58049211906     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2008.08.008     Document Type: Short Survey

References (111)

1. Holick M.F. Vitamin D deficiency. N Engl J Med 357 (2007) 266-281
2. Holick M.F. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81 (2006) 353-373
3. Khosla S. Minireview: the OPG/RANKL/RANK system. Endocrinology 142 (2001) 5050-5055
4. Dusso A.S., Brown A.J., and Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol 289 (2005) F8-F28
5. Deluca H.F. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 80 (2004) 1689S-1696S
6. Nagpal S., Na S., and Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 26 (2005) 662-687
7. Costa E.M., Blau H.M., and Feldman D. 1, 25-dihydroxyvitamin D3 receptors and hormonal responses in cloned human skeletal muscle cells. Endocrinology 119 (1986) 2214-2220
8. Kato S., Takeyama K., Kitanaka S., Murayama A., Sekine K., and Yoshizawa T.J. In vivo function of VDR in gene expression-VDR knock-out mice. J Steroid Biochem Mol Biol 69 (1999) 247-251
9. Selles J., and Boland R. Evidence on the participation of the 3′,5′-cyclic AMP pathway in the non-genomic action of 1, 25-dihydroxy-vitamin D3 in cardiac muscle. Mol Cell Endocrinol 82 (1991) 229-235
10. Arnson Y., Amital H., and Shoenfeld Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis 66 (2007) 1137-1142
11. Krall E.A., Sahyoun N., Tannenbaum S., Dallal G.E., and Dawson-Hughes B. Effect of vitamin D intake on seasonal variations in parathyroid hormone secretion in postmenopausal women. N Engl J Med 321 (1989) 1777-1783
12. Steingrimsdottir L., Gunnarsson O., Indridason O.S., Franzson L., and Sigursson G. Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA 9 (2005) 2336-2341
13. Binkley N., Novotny R., Krueger D., and Kawahara-Baccus T. Inadequate vitamin D status despite abundant sun exposure. J Bone Miner Res (2006) M473
14. Gannagé-Yared M.H., Chemali R., Yaacoub N., and Halaby G. Hypovitaminosis D in a sunny country: relation to lifestyle and bone markers. J Bone Miner Res 15 (2000) 1856-1862
15. Meddeb N., Sahli H., Chahed M., Abdelmoula J., Feki M., Salah H., et al. Vitamin D deficiency in Tunisia. Osteoporos Int 16 (2005) 180-183
16. Clemens T.L., Adams J.S., Henderson S.L., and Holick M.F. Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet 1 (1982) 74-76
17. Hannan M.T., Litman H.J., Araujo A.B., McLennan C.E., McLean R.R., McKinlay J.B., et al. Serum 25-hydroxyvitamin D and bone mineral density in a racially and ethnically diverse group of men. J Clin Endocrinol Metab 93 (2008) 40-46
18. Willis C.M., Laing E.M., Hall D.B., Hausman D.B., and Lewis R.D. A prospective analysis of plasma 25-hydroxyvitamin D concentrations in white and black prepubertal females in the southeastern Unites States. Am J Clin Nutr 85 (2007) 124-130
19. Reid I.R., Gallagher D.J., and Bosworth J. Prophylaxis against vitamin D deficiency in the elderly by regular sunlight sun exposure. Age ageing 15 (1986) 35-40
20. Wortsman J., Matsuoka L.Y., Chen T.C., Lu Z., and Holick M.F. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72 (2000) 690-693
21. Bolland M.J., Grey A.B., Ames R.W., Mason B.H., Horne A.M., Gamble G.D., et al. The effects of seasonal variation of 25-hydroxyvitamin D and fat mass on a diagnosis of vitamin D sufficiency. Am J Clin Nutr 86 (2007) 959-964
22. Chen T.C., Ingersoll D., Lu Z., Mathieu J., Forse A., and Holick M.F. Vitamin D content in body fat and the consequences of bariatric surgery on vitamin D status. J Bone Miner Res (2007) S196
23. Souberbielle J.C., Cormier C., Kindermans C., Gao P., Cantor T., Forette F., et al. Vitamin D status and redefining serum parathyroid hormone reference range in the elderly. J Clin Endocrinol Metab 86 (2001) 3086-3090
24. Chapuy M.C., Preziosi P., Maamer M., Arnaud S., Galan P., Hercberg S., et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 7 (1997) 439-443
25. Bischoff-Ferrari H.A., Giovannucci E., Willett W.C., Dietrich T., and Dawson-Hughes B. Estimation of optimal serum concentrations of 25 hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84 (2006) 18-28
26. Lips P., Hosking D., Lippuner K., Norquist J.M., Wehren L., Maalouf G., et al. The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. J Intern Med 260 (2006) 245-254
27. Simonelli C., Weiss T.W., Morancey J., Swanson L., and Chen Y.T. Prevalence of vitamin D inadequacy in a minimal trauma fracture population. Curr Med Res Opin 21 (2005) 1069-1074
28. Guardia G., Parikh N., Eskridge T., Phillips E., Divine G., and Rao D.S. Prevalence of vitamin D depletion among subjects seeking advice on osteoporosis: a five-year cross-sectional study with public health implications. Osteoporos Int 19 (2008) 13-19
29. Thomas M.K., Lloyd-Jones D.M., Thadhani R.I., Shaw A.C., Deraska D.J., Kitch B.T., et al. Hypovitaminosis D in medical inpatients. N Engl J Med 338 (1998) 777-783
30. Roth D.E., Martz P., Yeo R., Prosser C., Bell M., and Jones A.B. Are national vitamin D guidelines sufficient to maintain adequate blood levels in children?. Can J Public Health 96 (2005) 443-449
31. Gordon C.M., DePeter K.C., Feldman H.A., Grace E., and Emans S.J. Prevalence of vitamin D deficiency among healthy adolescents. Arch Pediatr Adolesc Med 158 (2004) 531-537
32. Feron F., Bume T.H., and Brown J. Developmental vitamin D3 deficiency alters the adult rat brain. Brain Res Bull 65 (2005) 141-148
33. Almeras L., Eyles D., and Benech P. Developmental vitamin D deficiency alters brain protein expression in the adult rat: implications for neuropsychiatrics disorders. Proteomics 7 (2007) 769-780
34. Bodnar L.M., Catov J.M., Roberts J.M., and Simhan H.N. High prevalence of vitamin D insufficiency in black and white pregnant women residing in the Northern United States and their neonates. J Nutr 137 (2007) 447-452
35. Nesby-O'Dell S., Scanlon K.S., Cogswell M.E., Gillespie C., Hollis B.W., Looker A.C., et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: thir national Health and Nutrition Examination Survey 1988-1994. Am J Clin Nutr 76 (2002) 187-192
36. Heaney R.P., Dowell M.S., Hale C.A., and Bendich A. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. Journal of American College of Nutrition 22 (2003) 142-146
37. Bischoff-Ferrari H.A., Dietrich T., Orav E.J., and Dawson-Hughes B. Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med 116 (2004) 634-639
38. Tang B.M.P., Eslick G.D., Nowson C., Smith C., and Bensoussan A. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 370 (2007) 657-666
39. Trivedi D.P., Doll R., and Khaw K.T. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 326 (2003) 469-475
40. Chapuy M.C., Arlot M.E., Duboeuf F., Brun J., Crouzet B., Arnaud S., et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 327 (1992) 1637-1642
41. Avenell A, Gillespie WJ, Gillespie LD, O'Connell DL. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev 2005; 20:CD000227.
42. Bischoff-Ferrari H.A., Willett W.C., Wong J.B., Giovannucci E., Dietrich T., and Dawson-Hughes B. Fracture prevention with vitamin D supplementation. A meta-analysis of randomized controlled trials. JAMA 293 (2005) 2257-2264
43. Grant A.M., Avenell A., Campbell M.K., McDonald A.M., MacLennan G.S., McPherson G.C., et al. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomized Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 365 (2005) 1621-1628
44. Lips P., Grafmans W.C., Ooms M.E., Bezemer P.D., and Bouter L.M. Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo controlled clinical trial. Ann Internb Med 124 (1996) 400-406
45. Jackson R.D., LaCroix A.Z., Gass M., Wallace R.B., Robbins J., Lewis C.E., et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 354 (2006) 669-683
46. Gerdhem P., Ringsberg K.A.M., Obrant K.J., and Akesson K. Association between 25-hydroxy vitamin D levels, physical activity, uscle strength and fractures in the prospective population-based OPRA Study of elderly women. Osteoporos Int 16 (2005) 1425-1431
47. Boonen S., Lips P., Bouillon R., Bischoff-Ferrari H.A., Vanderschueren D., and Haentjens P. Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative metaanalysis of randomized controlled trials. J Clin Endocrinol Metab 92 (2007) 1415-1423
48. Barone A., Giusti A., and Pioli G. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial. JAGS 55 (2007) 752-757
49. Deane A., Constancio L., Fogelman I., and Hampson G. The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis. BMC Musculoskeletal Disorders 8 (2007) 1-8
50. Bischoff-Ferrari H.A., Borchers M., Gudat F., Dürmuller U., Stâhelin H.B., and Dick W. Vitamin D receptor expression in human muscle tissue decreases with age. J Bone Miner Res 19 (2004) 265-269
51. Bischoff-Ferrari H.A., Dietrich T., Orav E.J., Hu F.B., Zhang Y., Karlson E.W., et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged ≥ 60y. Am J Clin Nutr 80 (2004) 752-758
52. Vind A.B., Andersen H.E., and Schwartz P. The prevalence of osteoporosis and vitamin D deficiciency/insufficiency among elderly people with falls in Denmark. J Bone Miner Res (2007) S344
53. Bischoff-Ferrari H.A., Dawson-Hughes B., Willett W.C., Staehelin H.B., Bazemore M.G., Zee R.Y., et al. Effect of vitamin D on falls. A meta-analysis. JAMA 16 (2004) 1999-2006
54. Gallagher J.C., Fowler S.E., Detter J.R., and Sherman S.S. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss. J Clin Endocrinol Metab 86 (2001) 3618-3628
55. Broe K.E., Chen T.C., Weinberg J., Bischoff-Ferrari H.A., Holick M.F., and Kiel D.P. A higher dose of vitamin D reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J Am Geriatr Soc 55 (2007) 234-239
56. Pfeifer M., Begerow B., Minne H.W., Suppan K., Fahrleitner-Pammer A., and Dobnig H. Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals. Osteoporos Int (2008) DOI: 10.1007/s00198-008-0662-7
57. Dhesi J.K., Jackson S.H., Bearne L.M., Moniz C., Hurley M.V., Swift C.G., et al. Vitamin D supplementation improves neuromuscular function in older people who fall. Age and ageing 3 (2004) 589-595
58. Bischoff-Ferrari H.A., Conzelmann M., Stähelin H.B., Dick W., Carpenter M.G., and Adkin A.L. Is fall prevention by vitamin D mediated by a change in postural or dynamic balance?. Osteoporos Int 17 (2006) 656-663
59. Garland C.F., Garland F.C., Gorham E.D., Lipkin M., Newmark H., Mohr S.B., et al. The role of vitamin D in cancer prevention. Am J Public Health 96 (2006) 252-261
60. Luscombe C.J., Fryer A.A., French M.E., Liu S., Saxby M.F., Jones P.W., et al. Exposure to ultraviolet radiation association with susceptibility and age at presentatopn with prostate cancer. Lancet 358 (2001) 641-642
61. Garland C.F., Comstock G.W., Garland F.C., Helsing K.J., Shaw E.K., and Gorham E.D. Lancet 18 (1989) 1176-1178
62. Feskanich D., Ma J., Fuchs C.S., Kirkner G.J., Hankinson S.E., Hollis B.W., et al. Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 13 (2004) 1502-1508
63. Lappe J.M., Travers-Gustafson D., Davies K.M., Recker R.R., and Heaney R.P. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 85 (2007) 1586-1591
64. Gorham E.D., Garland C.F., Garland F.C., Grant W.B., Mohr S.B., Lipkin M., et al. Optimal vitamin D status for colorectal cancer prevention: a quantitative meta-analysis. Am J Prev Med 32 (2007) 210-216
65. Garland C.F., Gorham E.D., Mohr S.B., Grant W.B., Giovannucci E.L., Lipkin M., et al. Vitamin D and prevention of breast cancer pooled analysis. J Steroid Biochem Mol Biol 103 (2007) 708-711
66. Wactawski-Wende J., Kotchen J.M., Anderson G.L., Assaf A.R., Brunner R.L., O'Sullivan M.J., et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 354 (2006) 684-696
67. Bertone-Johnson E.R., Chen W.Y., Holick M.F., Hollis B.W., Colditz G.A., Willett W.C., et al. Plasma 25-hydroxyvitamin D and 1, 25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 14 (2005) 1991-1997
68. Ponsonby A.L., McMichael A., and van der Mei I. Ultraviolet radiation and autoimmunity disease: insights from epidemiological research. Toxicology 181 (2002) 71-78
69. Mark B.L., and Carson J.A. Vitamin D and autoimmune disease, implications for practice from the multiple sclerosis literature. J Am Diet Assoc 106 (2006) 418-424
70. Munger K.L., Levin L.I., Hollis B.W., Howard N.S., and Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple schlerosis. JAMA 296 (2006) 2832-2838
71. Munger K.L., DeLorenze G.N., Levin L.I., Rubertone M.V., Vogelman J.H., Peck C.A., et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 62 (2004) 60-65
72. Hyppönen E., Läärä E., Reunanen A., Järvelin M.R., Virtanen S.M., Hypponën E., et al. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 358 (2001) 1500-1503
73. Chiu K.C., Chu A., Go V.L.W., and Saad M.F. Hypovitaminosis D is associated with insulin resistance and β cell dysfunction. Am J Clin Nutr 79 (2004) 820-825
74. Pittas A.G., Dawson-Hughes B., Li T., Van Dam R.M., Willett W.C., Manson J.E., et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 29 (2006) 650-656
75. Merlino L.A., Curtis J., Mikuls T.R., Cerhan J.R., Criswell L.A., Saag K.G., et al. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum 50 (2004) 72-77
76. Jahnsen J., Falch J.A., Mowinckel P., and Aadland E. Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol 37 (2002) 192-199
77. Cantorna M.T., Munsick C., Bemiss C., and Mahon B.D. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr 130 (2000) 2648-2652
78. Zasloff M. Fighting infections with vitamin D. Nat Med 12 (2006) 388-390
79. Liu P.T., Stenger S., Li H., Wenzel L., Tan B.H., Krutzik S.R., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311 (2006) 1770-1773
80. Cannell J.J., Vieth R., Umhau J.C., Holick M.F., Grant W.B., Madronich S., et al. Epidemic influenza and vitamin D. Epidemiol Infect 134 (2006) 1129-1140
81. Aloia J.F., and Li-Ng M. Re: epidemic influenza and vitamin D. Epidemiol Infect 135 (2007) 1095-1096
82. Payne J.B., Reinhardt R.A., Nummikoski P.V., and Patil K.D. Longitudinal alveolar bone loss in postmenopausal osteoporotic/osteopenic women. Osteoporos Int 10 (1999) 34-40
83. Dietrich T., Nunn M., Dawson-Hughes B., and Bischoff-Ferrari H.A. Association between serum concentrations of 25-hydroxyvitamin D and gingival inflammation. Am J Clin Nutr 82 (2005) 575-580
84. Dietrich T., Joshipura K.J., Dawson-Hughes B., and Bischoff-Ferrari. Association between serum concentrations of 25-hydroxyvitamin D and periodontal disease in the US population. Am J Clin Nutr 80 (2004) 108-113
85. Krall E.A., Wehler C., Garcia R.I., Harris S.S., and Dawson-Hughes B. Calcium and vitamin D supplements reduce tooth loss in the elderly. Am J Med 111 (2001) 452-456
86. Forman J.P., Giovannucci E., Holmes M.D., Bischoff-Ferrari H.A., Tworoger S.S., Willett W.C., et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 49 (2007) 1063-1069
87. Wang T.J., Pencina M.J., Booth S.L., Jacques P.F., Ingelsson E., Lanier K., et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 117 (2008) 503-511
88. Zitterman A., Schleithoff S.S., Tenderich G., Berthold H.K., Körfe R., and Stehle P. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure?. J Am Coll Cardiol 41 (2003) 105-112
89. Hsia J., Heiss G., Ren H., Allison M., Dolan N.C., Greenland P., et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation 115 (2007) 846-854
90. Poole A.R., Nelson F., Hollander A., Reiner A., Pidoux I., and Ionescu M. Collagen II turnover in joint diseases. Acta Orthop Scand 266 (1995) 88-91
91. McAlindon T.E., Felson D.T., Zhang Y., Hannan M.T., Aliabadi P., Weissman B., et al. Relation of dietary intake and serum levels of vitamin D to progression of osteoarthritis of the knee among participants in the Framingham Study. Ann Intern Med 125 (1996) 353-359
92. Lane N.E., Gore L.R., Cummings S.R., Hochberg M.C., Scott J.C., Williams E.N., et al. Serum vitamin D levels and incident changes of radiographic hip osteoarthritis: a longitudinal study. Study of Osteoporotic Fractures. Arthritis Rheum 42 (1999) 854-860
93. Felson D.T., Niu J., Clancy M., Aliabadi P., Sack B., Guermazi A., et al. Low levels of vitamin D and worsening of knee osteoarthritis. Results of two longitudinal studies. Arthritis Rheum 56 (2007) 129-136
94. Autier P., and Gandini S. Vitamin D supplementation and total moratlity. A meta-analysis of randomized controlled trials. Arch Intern Med 167 (2007) 1730-1737
95. Visser M., Deeg D.J.H., Puts Mte, Seidell J.C., and Lips P. Low serum concentrations of 25-hydroxyvitamin D in older persons and the risk of nursing home admission. Am J Clin Nutr 84 (2006) 616-622
96. Vieth R. Vitamin D supplementation, 25-hydroxy-vitamin D concentrations, and safety. Am J Clin Nutr 69 (1999) 842-846
97. Hathcock J.N., Shao A., Vieth R., and Heaney R. Risk assessment for vitamin D. Am J Clin Nutr 85 (2007) 6-18
98. Heaney R.P., Davies K.M., Chen T.C., Holick M.F., and Barger-Lux M.J. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 77 (2003) 204-210
99. Hollis B.W., and Wagner C.L. Vitamin D requirements during lactation: high-dose maternal supplementation as therapy to prevent hypovitaminosis D for both the mother and the nursing infant. Am J Clin Nutr 80 (2004) 1752S-1758S
100. Barger-Lux M.J., Heaney R.P., Dowell S., Chen T.C., and Holick M.F. Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporos Int 8 (1998) 222-230
101. Holick M.F. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79 (2004) 362-371
102. Reichrath J. The challenge resulting from positive and negative effects of sunlight. How much solar UV exposure is appropriate to balance between risks of vitamin D deficiency and skin cancer?. Progress in Biophysics and Molecular Biology 92 (2006) 9-16
103. Holick M.F., Biancuzzo R.M., Chen T.C., Klein E.K., Young A., Bibuld D., et al. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 93 (2008) 677-681
104. Armas L.A., Hollis B.W., and Heaney R.P. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 89 (2004) 5387-5391
105. Vieth R., Ladak Y., and Walfish P.G. Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. J Clin Endocrinol Metab 88 (2003) 185-191
106. Cannell J.J., Hollis B.W., Zasloff M., and Heaney R.P. Diagnosis and treatment of vitamin D deficiency. Expert Opin Pharmacother 9 (2008) 107-118
107. Holick M.F. Vitamin D requirements for humans of all ages: new increased requirements for women and men 50 years and older. Osteoporos Int 8 (1998) S24-S29
108. Bischoff-Ferrari H.A. How to select the doses of vitamin D in the management of osteoporosis. Osteoporos Int 18 (2007) 401-407
109. Chel V., Wijnhoven H.A.H., Smit J.H., Ooms M., and Lips P. Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents. Osteoporos Int 19 (2008) 663-671
110. AFSSA. Les apports nutritionnels conseillés pour la population française. 3ème édition. Paris : Editions TEC 1 DOC; 2001.
111. INRA. Répertoire général des aliments. Table de composition. 2e édition. Paris : Editions TEC 1 DOC; 1995.